Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

INSHyperproinsulinemia

Four Japanese families with familial hyperproinsulinemia exhibited a shared alteration at Arg65 of proinsulin, implicating this residue as a mutational hotspot (PMID:7859596). Affected individuals demonstrated elevated proinsulin-to-insulin ratios and abnormal insulin release profiles consistent with impaired B–C junction cleavage. Segregation across each kindred supports an autosomal dominant inheritance pattern with co-segregation of the Arg65 locus and biochemical phenotype. While the precise nucleotide change remains to be defined, functional assays revealed defective proinsulin processing in affected subjects (PMID:7859596). No conflicting reports have been documented for INS in hyperproinsulinemia. Key take-home: INS Arg65 variants cause a cleavage defect leading to hyperproinsulinemia and should be considered in diagnostic sequencing of familial cases.

References

  • Diabetes research and clinical practice • 1994 • Hyperproinsulinemia in Japan PMID:7859596

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Four unrelated probands in independent families with INS Arg65 involvement ([PMID:7859596])

Genetic Evidence

Limited

Four families with segregation of elevated proinsulin and an Arg65 locus without precise molecular characterisation ([PMID:7859596])

Functional Evidence

Limited

In vitro insulin release assays demonstrated impaired proinsulin processing in affected individuals ([PMID:7859596])